Estrogen Effects on Skeletal Muscle

Chapter

Abstract

In the past several decades the importance of the sex hormone estrogen for the overall health and well-being of skeletal muscle has become apparent, particularly for women, but also in men. In the early 1990s an article appeared indicating that skeletal muscle may be an estrogen (E2) target and that E2 impacted muscle strength. This seminal article was published by Phillips et al. [1] and indicated that women who were on hormone replacement therapy (HRT) through the menopause maintained the strength (force/muscle mass) of their adductor pollicis muscle compared with women who were not on HRT. Findings suggested that E2 provided a protective effect on muscle strength loss with aging that was maintained until women were approximately 70 years of age. Since that time hundreds of studies have been conducted and our understanding of E2 effects on skeletal muscle has grown substantially. The purpose of this chapter is to summarize recent findings on known E2 effects on skeletal muscle but also indicate some of the questions that remain.

References

  1. 1.
    Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC (1993) Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) 84:95–98Google Scholar
  2. 2.
    Lieberman SA, Oberoi AL, Gilkison CR, Masel BE, Urban RJ (2001) Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab 86(6):2752–2756PubMedCrossRefGoogle Scholar
  3. 3.
    Sheffield-Moore M, Urban RJ (2004) An overview of the endocrinology of skeletal muscle. Trends Endocrinol Metab 15(3):110–115PubMedCrossRefGoogle Scholar
  4. 4.
    Vernikos J, Dallman MF, Keil LC, O'Hara D, Convertino VA (1993) Gender differences in endocrine responses to posture and 7 days of −6 degrees head-down bed rest. Am J Physiol 265(1 Pt 1):E153–E161PubMedGoogle Scholar
  5. 5.
    Sternfeld B, Bhat AK, Wang H, Sharp T, Quesenberry CP (2005) Menopause, physical activity, and body composition/fat distribution in midline women. Med Sci Sports Exerc 37:1195–1202PubMedCrossRefGoogle Scholar
  6. 6.
    Sipila S (2003) Body composition and muscle performance during menopause and hormone replacement therapy. J Endocrinol Invest 26(9):893–901PubMedGoogle Scholar
  7. 7.
    Vernikos J, Schneider VS (2010) Space, gravity and the physiology of aging: parallel or convergent disciplines? a mini-review. Gerontology 56(2):157–166PubMedCrossRefGoogle Scholar
  8. 8.
    Greeves JP, Cable NT, Reilly R, Kingsland C (1999) Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci 97:79–84PubMedCrossRefGoogle Scholar
  9. 9.
    Rolland YM, Perry HM, Patrick P, Banks WA, Morley JE (2007) Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci 62A:330–335CrossRefGoogle Scholar
  10. 10.
    Taaffe DR et al (2005) Estrogen replacement, muscle composition, and physical function: The Health ABC Study. Med Sci Sports Exerc 37(10):1741–1747PubMedCrossRefGoogle Scholar
  11. 11.
    Chen Z, Bassford T, Green SB et al (2005) Postmenopausal hormone therapy and body composition: a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr 82:651–656PubMedGoogle Scholar
  12. 12.
    Ronkainen PHA, Kovanen V, Alen M et al (2009) Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs. J Appl Physiol 107:25–33PubMedCrossRefGoogle Scholar
  13. 13.
    Douchi T, Kuwahata R, Yamasaki H, Yamamoto S, Oki T, Nakae M, Nagata Y (2002) Inverse relationship between the changes in trunk lean and fat mass during gonadotropin-releasing hormone agonist therapy. Maturitas 42:31–35PubMedCrossRefGoogle Scholar
  14. 14.
    Kenny AM, Dawson L, Kleppinger A, Ianuzzi-Sucich M, Judge JO (2003) Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. J Gerontol A Biol Sci Med Sci 58:M436–M440PubMedCrossRefGoogle Scholar
  15. 15.
    Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M (2012 Nov) The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci 67:1140–1152PubMedCrossRefGoogle Scholar
  16. 16.
    Moran AL, Warren GL, Lowe DA (2006) Removal of ovarian hormones from mature mice detrimentally affects muscle contractile function and myosin structural distribution. J Appl Physiol 100(2):548–559PubMedCrossRefGoogle Scholar
  17. 17.
    Moran AL et al (2007) Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice. J Appl Physiol 102(4):1387–1393PubMedCrossRefGoogle Scholar
  18. 18.
    Greising SM et al (2009) Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci 64(10):1071–1081PubMedCrossRefGoogle Scholar
  19. 19.
    Brown M et al (2009) Estrogen receptor-alpha and -beta and aromatase knockout effects on lower limb muscle mass and contractile function in female mice. Am J Physiol Endocrinol Metab 296(4):E854–E861PubMedCrossRefGoogle Scholar
  20. 20.
    van Geel TACM, Geusens PP, Winkens B, Sels J-PJE, Dinant G-J (2009) Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol 160:681–687PubMedCrossRefGoogle Scholar
  21. 21.
    Petrella J, Kim JS, Tuggle SC, Hall SR, Bamman MM (2005) Age differences in knee extension power, contractile velocity, and fatigability. J Appl Physiol 98:211–219PubMedCrossRefGoogle Scholar
  22. 22.
    Sipila S, Poutamo J (2003) Muscle performance, sex hormones and training in peri-menopausal and post-menopausal women. Scand J Med Sci Sports 13:19–25PubMedCrossRefGoogle Scholar
  23. 23.
    Taafe DR, Sipila S, Cheng S, Populakka J, Toivanen J, Souminen H (2005) The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention. Clin Physiol Funct Imaging 25:297–304CrossRefGoogle Scholar
  24. 24.
    Brown M, Birge S, Kohrt WM (1997) Hormone replacement does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise. J Gerontol A Biol Sci Med Sci 52:B166–B170PubMedCrossRefGoogle Scholar
  25. 25.
    Greising SM, Baltgalvis KA, Kosir AM, Moran AL, Warren GL, Lowe DA (2011) Estradiol's beneficial on murine muscle function is independent of muscle activity. J Appl Physiol 110:109–115PubMedCrossRefGoogle Scholar
  26. 26.
    Wiik A, Hellsten Y, Berthelson P, Lundholm L, Fischer H, Jansson E (2008) Activation of estrogen response elements is mediated both via estrogen and muscle contractions in rat skeletal muscle myotubes. Am J Physiol Cell physiol 296:C215–C220PubMedCrossRefGoogle Scholar
  27. 27.
    Galuzzo P, Rastellli C, Bulzomi P, Acconcia F, Pallottini V, Marino M (2009) 17-β-Estradiol regulates the first steps of skeletal muscle cell differentation via ERα-mediated signals. Am J Physiol Cell Physiol 297:C1249–C1262CrossRefGoogle Scholar
  28. 28.
    Baltgalvis KA, Greising SM, Warren GL, Lowe DA (2010) EStrogen regulates estrogen receptors and antioxidant gene expression in mouse skeletal muscle. PLoS One 5:1–11CrossRefGoogle Scholar
  29. 29.
    Dieli-Conwright CM et al (2010) Hormone replacement therapy and messenger RNA expression of estrogen receptor coregulators after exercise in postmenopausal women. Med Sci Sports Exerc 42(3):422–429PubMedCrossRefGoogle Scholar
  30. 30.
    Petterson K, Delaunay F, Gustafsson J-A (2000) Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 19:4970–4978CrossRefGoogle Scholar
  31. 31.
    Kahlert S, Grohe C, Karas RH, Lobbert K, Neyses L, Vetter H (1997) Effects of estrogen on skeletal myoblast growth. Biochem Biophys Res Commun 232:373–378PubMedCrossRefGoogle Scholar
  32. 32.
    Boland R, Vasconsuelo A, Milanesi L, Ronda AC, Boland AR (2008) 17β-estradiol signaling in skeletal muscle cells and its relationshiop to apoptosis. Steroids 73:859–863PubMedCrossRefGoogle Scholar
  33. 33.
    Hagberg JM, McCole SD, Ferrell RE, Zmuda JM, Rodgers KS, Wilund KR, Moore GE (2003) Physical activity, hormone replacement therapy and plasma lipoprotein-lipid levels in postmenopausal women. Int J Sports Med 24:22–29PubMedCrossRefGoogle Scholar
  34. 34.
    Eckel LA, Moore SR (2004) Diet-induced hyperphasia in the rat is influenced by sex and exercise. Am J Physiol Regul Integr Comp Physiol 287:R1080–R1085PubMedCrossRefGoogle Scholar
  35. 35.
    Tou J, Wade CE (2002) Determinants affecting physical activity levels in animal models. Exp Biol Med 227:587–600Google Scholar
  36. 36.
    Tiidus PM, Deller M, Liu XL (2005) Oestrogen influence on myogenic satellite cells following downhill running in male rats: a preliminary study. Acta Physiol Scand 184(1):67–72PubMedCrossRefGoogle Scholar
  37. 37.
    Enns DL, Tiidus PM (2008) Estrogen influences satellite cell activation and proliferation following downhill running in rats. J Appl Physiol 104(2):347–353PubMedCrossRefGoogle Scholar
  38. 38.
    Thomas A, Bunyan K, Tiidus PM (2010) Oestrogne receptor-alpha activation augments post-exercise myoblast proliferation. Acta Physiol 198:81–89CrossRefGoogle Scholar
  39. 39.
    Dieli-Conwright CM, Spektor TM, Rice JC, Schroeder ET (2009) Hormone therapy attenuates exercise-indiced skeletal muscle damage in postmenopausal women. J Appl Physiol 107:853–858PubMedCrossRefGoogle Scholar
  40. 40.
    Brown M, Foley A, Ferreria JA (2005) Ovariectomy, hindlimb unweighting, and recovery effects on skeletal muscle in adult rats. Aviat Space Environ Med 76(11):1012–1018PubMedGoogle Scholar
  41. 41.
    Sitnick M et al (2006) Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle mass. J Appl Physiol 100(1):286–293PubMedCrossRefGoogle Scholar
  42. 42.
    McClung JM et al (2006) Estrogen status and skeletal muscle recovery from disuse atrophy. J Appl Physiol 100:2012–2023PubMedCrossRefGoogle Scholar
  43. 43.
    Rothman MS, Arciniegas DB, Filley CM, Wierman ME (2007) The neuroendocrine effects of traumatic brain injury. J Neuropsychiatry Clin Neurosci 19:363–372PubMedCrossRefGoogle Scholar
  44. 44.
    Sugiura T et al (2006) Estrogen administration attenuates immobilization-induced skeletal muscle atrophy in male rats. J Physiol Sci 56:393–399PubMedCrossRefGoogle Scholar
  45. 45.
    Wierman ME, Kohrt WM (2007) Vascular and metabolic effects of sex steroids: new insights into clinical trials. Reprod Sci 14:300–314PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Physical TherapyUniversity of MissouriColumbiaUSA

Personalised recommendations